Filing Details

Accession Number:
0000711377-12-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-17 18:30:23
Reporting Period:
2012-08-15
Filing Date:
2012-08-17
Accepted Time:
2012-08-17 18:30:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-15 6,299 $13.55 127,986 No 4 M Direct
Common Stock Disposition 2012-08-15 6,299 $38.89 121,687 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2012-08-15 6,299 $0.00 6,299 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
178,876 2012-08-09 2012-08-16 No 4 M Direct